NOXXON Pharma Closes €33M Round of Financing
NOXXON Pharma AG, a Berlin, Germany-based company focused on the development of mirror image oligonucleotide therapeutics, closed a €33m Series D round of financing. The round was led by new investor NGN Capital, with participation from existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow […]